What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells.

Reconstruction of large bone defects or non-unions resulting from biochemical disorders, tumour resections or complicated fractures is still a challenge for orthopaedic and trauma surgery. On the one hand, autografts harbour most features of ideal bone graft substitutes but on the other hand, they have a lot insurmountable disadvantages. An ideal bone graft substitute should be biomechanically stable, able to degrade within an appropriate time frame, exhibit osteoconductive, osteogenic and osteoinductive properties and provide a favourable environment for invading blood vessels and bone forming cells. Whilst osteoconductivity of biomaterials for bone tissue engineering strategies can be directed by their composition, surface character and internal structure, osteoinductive and osteogenic features can be provided by growth factors originally participating in fracture healing and/or multipotent mesenchymal stromal/stem cells (MSC) capable of rebuilding bone and marrow structures. In this review, aspects of the clinical application of the most commonly used growth factors for bone repair, the bone morphogenetic proteins (BMPs), and the potential use of human MSC for clinical application will be discussed.

[1]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.

[2]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[3]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[4]  N. Haas,et al.  Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. , 2007, Injury.

[5]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[6]  R. Midura,et al.  Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  L. Yahia,et al.  Natural coral exoskeleton as a bone graft substitute: a review. , 2002, Bio-medical materials and engineering.

[8]  Hans Hauner,et al.  Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. , 2003, Arthritis and rheumatism.

[9]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[10]  M Bohner,et al.  Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. , 2000, Injury.

[11]  N. P. Haas,et al.  Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. , 2006, Bone.

[12]  M. Bouxsein,et al.  Direct percutaneous gene delivery to enhance healing of segmental bone defects. , 2006, The Journal of bone and joint surgery. American volume.

[13]  Maurilio Marcacci,et al.  Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. , 2007, Tissue engineering.

[14]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[15]  J. Gimble,et al.  Multipotential human adipose‐derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo , 2008, Journal of cellular physiology.

[16]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  R Cancedda,et al.  Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.

[18]  Julian R. Jones,et al.  Porous bioactive nanostructured scaffolds for bone regeneration: a sol-gel solution. , 2008, Nanomedicine.

[19]  C. Boehm,et al.  Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. , 2005, The Journal of bone and joint surgery. American volume.

[20]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[21]  A. Wentzensen,et al.  Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. , 2009, Injury.

[22]  S. Deb,et al.  In vitro proliferation and differentiation of human mesenchymal stem cells on hydroxyapatite versus human demineralised bone matrix with and without osteogenic protein-1. , 2009, Expert opinion on biological therapy.

[23]  Christian Clausen,et al.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. , 2003, Bone.

[24]  Franca Fagioli,et al.  Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow , 2006, Journal of cellular biochemistry.

[25]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[26]  Katrine Frønsdal,et al.  In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability , 2005, Stem cells.

[27]  H. Seeherman,et al.  rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  W. Hayes,et al.  Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  N. Haas,et al.  Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats. , 2004, Bone.

[30]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[31]  E. Chao,et al.  Biophysical stimulation of bone fracture repair, regeneration and remodelling. , 2003, European cells & materials.

[32]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[33]  H. Chambers,et al.  Complications of iliac crest bone graft harvesting. , 1996, Clinical orthopaedics and related research.

[34]  M. Mastrogiacomo,et al.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. , 2000, Experimental hematology.

[35]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[36]  Marc A. Asher,et al.  Iliac Crest Bone Graft Harvest Donor Site Morbidity: A Statistical Evaluation , 1995, Spine.

[37]  M. Teschner.  [Tissue engineering of bone tissue]. , 1999, Zeitschrift fur Orthopadie und ihre Grenzgebiete.

[38]  N P Haas,et al.  Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. , 2002, Bone.

[39]  N. Haas,et al.  Quantification of various growth factors in different demineralized bone matrix preparations. , 2007, Journal of biomedical materials research. Part A.

[40]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[41]  W. Richter,et al.  Calcification or dedifferentiation: Requirement to lock mesenchymal stem cells in a desired differentiation stage , 2009, Journal of cellular physiology.

[42]  N P Haas,et al.  Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. , 2001, Bone.

[43]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[44]  K. Le Blanc.  Mesenchymal stromal cells: Tissue repair and immune modulation. , 2006, Cytotherapy.

[45]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[46]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[47]  M. Bouxsein,et al.  Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects , 2007, Gene Therapy.

[48]  H. Pape,et al.  Tissue Engineering von Knochengewebe , 2009, Der Unfallchirurg.

[49]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[50]  Joseph M. Lane,et al.  Bone Morphogenic Protein Science and Studies , 2005, Journal of orthopaedic trauma.

[51]  B. Riggs,et al.  Isolation and characterization of osteoblast precursor cells from human bone marrow , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  P. Kasten,et al.  Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. , 2008, Acta biomaterialia.

[53]  V. Goldberg,et al.  Culture‐expanded human periosteal‐derived cells exhibit osteochondral potential in vivo , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[54]  Yugyung Lee,et al.  Biomedical applications of collagen. , 2001, International journal of pharmaceutics.

[55]  K. Satomura,et al.  Repair of craniotomy defects using bone marrow stromal cells. , 1998, Transplantation.

[56]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  N. Nardi,et al.  In Search of the In Vivo Identity of Mesenchymal Stem Cells , 2008, Stem cells.

[58]  P. Emery,et al.  Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. , 2010, Arthritis and rheumatism.

[59]  B. Schmidt-Rohlfing,et al.  [Tissue engineering of bone tissue. Principles and clinical applications]. , 2009, Der Unfallchirurg.

[60]  A. Ho,et al.  Mesenchymal Stem Cell Preparations—Comparing Apples and Oranges , 2007, Stem Cell Reviews.

[61]  A. Ruys,et al.  Biodegradable poly(alpha-hydroxy acid) polymer scaffolds for bone tissue engineering. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[62]  A Kingman,et al.  In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. , 2001, Biotechnology and bioengineering.

[63]  Abhay Pandit,et al.  Fabrication methods of porous metals for use in orthopaedic applications. , 2006, Biomaterials.

[64]  S. Bruder,et al.  Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.

[65]  L. Tagliabue,et al.  An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. , 2006, Injury.

[66]  P. Chistolini,et al.  Biomechanical evaluation of cell-loaded and cell-free hydroxyapatite implants for the reconstruction of segmental bone defects , 1999, Journal of materials science. Materials in medicine.

[67]  Banwart Jc,et al.  Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. , 1995 .

[68]  S. Both,et al.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells , 2004, Journal of materials science. Materials in medicine.

[69]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[70]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[71]  A. Fronek,et al.  Principles and Clinical Applications , 1997 .

[72]  S. Ahmed,et al.  Biology and clinical applications , 2004 .

[73]  A. Caplan.  Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.

[74]  S. Both,et al.  Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. , 2002, Tissue engineering.

[75]  G. Daculsi,et al.  Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. , 1998, Biomaterials.

[76]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[77]  C. Boehm,et al.  Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume* , 1997, The Journal of bone and joint surgery. American volume.

[78]  T. Mittlmeier,et al.  IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. , 2002, Spine.

[79]  Stan Gronthos,et al.  The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair , 2009, Journal of cellular physiology.

[80]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[81]  F. Djouad,et al.  Multipotent mesenchymal stromal cells and immune tolerance , 2007, Leukemia & lymphoma.

[82]  Ralph Müller,et al.  In vivo behavior of calcium phosphate scaffolds with four different pore sizes. , 2006, Biomaterials.

[83]  R. Delamarter,et al.  Intervariability and Intravariability of Bone Morphogenetic Proteins in Commercially Available Demineralized Bone Matrix Products , 2006, Spine.

[84]  K. Kusumoto,et al.  Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. , 2000, International journal of oral and maxillofacial surgery.

[85]  K. Kusumoto,et al.  Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. , 1998, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[86]  R Cancedda,et al.  A nude mouse model for human bone formation in unloaded conditions. , 1998, Bone.

[87]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[88]  P. Kasten,et al.  Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation. , 2010, Acta biomaterialia.

[89]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[90]  Rodolfo Quarto,et al.  Cell Therapy for Bone Disease: A Review of Current Status , 2003, Stem cells.

[91]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[92]  P. Pizzutillo.  Rockwood and Wilkins' Fractures in Children. 6th ed. , 2006 .

[93]  O. Fromigué,et al.  Osteogenic differentiation of human marrow-derived mesenchymal stem cells. , 2006, Regenerative medicine.

[94]  N. Reimers,et al.  Biomechanics of femoral interlocking nails. , 2000, Injury.

[95]  Philip Kasten,et al.  Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. , 2005, Biomaterials.

[96]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[97]  C. Boehm,et al.  Age‐ and gender‐related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[98]  Paolo Giannoni,et al.  Tissue engineering and cell therapy of cartilage and bone. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[99]  Chikara Ohtsuki,et al.  Bioactive ceramic-based materials with designed reactivity for bone tissue regeneration , 2009, Journal of The Royal Society Interface.

[100]  D. Rowe,et al.  Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. , 1997, Transplantation.

[101]  M. A. Leroux,et al.  Treatment of inflammatory diseases with mesenchymal stem cells. , 2009, Inflammation & allergy drug targets.

[102]  A Boyde,et al.  Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.

[103]  P. Hernigou,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. , 2006, The Journal of bone and joint surgery. American volume.